Status:
TERMINATED
Surveillance For New Lung Primaries
Lead Sponsor:
University of Wisconsin, Madison
Conditions:
Lung Cancer
Eligibility:
All Genders
Brief Summary
The primary goal of this study is to determine the prevalence of tracheobronchial carcinomas in patients with a history of squamous cell cancer of the aerodigestive tract who have been treated with a ...
Eligibility Criteria
Inclusion
- History squamous cell NSCLC who have undergone complete resection or definitive chemotherapy
Exclusion
- History of an aerodigestive tract carcinoma of non-squamous histology
- Patients who have Stage IIIA, IIIB or IV squamous cell lung cancer that have undergone resection or chemotherapy within three years
- Patients who have Stage I or II squamous cell lung cancer that have undergone resection or chemotherapy within one year
- Patients who have received external beam radiation therapy for treatment of a squamous cell cancer of the lung
Key Trial Info
Start Date :
December 1 2001
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 1 2005
Estimated Enrollment :
200 Patients enrolled
Trial Details
Trial ID
NCT00205439
Start Date
December 1 2001
End Date
December 1 2005
Last Update
November 15 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Wisconsin Hospital and Clinics
Madison, Wisconsin, United States, 53792